Scientific Discussion & Quality Appraisal & GRADE Reporting

I authored the Discussion section, providing a deep-dive into the cardioprotective mechanisms of SGLT-2i and Metformin. I also applied the GRADE framework to evaluate the certainty of evidence for all clinical outcomes. I transformed complex statistical data into actionable clinical insights, highlighting a 64% reduction in heart failure risk and identifying key gaps for future trials.